ArticleBMJ open2025

Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.

Toshiyuki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.